HomeECX • FRA
add
Epigenomics AG
Previous close
€1.00
Day range
€0.85 - €0.85
Year range
€0.50 - €2.30
Market cap
745.15K EUR
Avg Volume
44.00
P/E ratio
-
Dividend yield
-
Primary exchange
FRA
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 47.00K | -31.00% |
Operating expense | 519.00K | 124.68% |
Net income | -1.28M | -167.97% |
Net profit margin | -2.72K | -198.50% |
Earnings per share | — | — |
EBITDA | 100.50K | -95.64% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 927.00K | -55.94% |
Total assets | 11.85M | -7.73% |
Total liabilities | 22.71M | 8.88% |
Total equity | -10.86M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | -9.96% | — |
Return on capital | -226.49% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.28M | -167.97% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Epigenomics AG is a molecular diagnostics company headquartered in Berlin, Germany with a wholly owned subsidiary, Epigenomics Inc. based in Seattle, WA. Wikipedia
Founded
1998
Headquarters
Website
Employees
6
